Haemonetics Corp (HAE)

$62.34 +0.66 (1.07%)
Market Cap 2.87B
Revenue (ttm) 1.36B
Net Income (ttm) 167.68M
EPS (ttm) N/A
PE Ratio 12.46
Forward PE 12.39
Profit Margin 12.32%
Debt to Equity Ratio 1.01
Volume 583,600
Avg Vol 859,750
Day's Range N/A - N/A
Shares Out 46.47M
Stochastic %K 87%
Beta 0.28
Analysts Strong Sell
Price Target $88.00

Company Profile

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLy...

Industry: Medical Devices
Sector: Healthcare
Phone: 781 848 7100
Address:
125 Summer Street, Boston, United States
OpenOutcrier
OpenOutcrier Feb. 24 at 2:05 PM
$HAE (+2.0% pre) New Haemonetics tech helps plasma centers collect more per donor https://ooc.bz/l/94447
0 · Reply
ClassiTrader
ClassiTrader Feb. 23 at 9:42 PM
$HAE $HAEMONETICS Corp Mass Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
0 · Reply
alshamiak
alshamiak Feb. 22 at 3:22 PM
$HAE #SWING
0 · Reply
dred48
dred48 Feb. 18 at 3:20 PM
$HAE switch turned on again
0 · Reply
Renecurtis
Renecurtis Feb. 9 at 4:27 PM
$HAE waiting for that 51$ to enter here
0 · Reply
Cutlass
Cutlass Feb. 6 at 3:44 PM
$HAE Load Zone 44 - 52 ✍️ Gap Nov 5 at 51.72 👀
0 · Reply
ZacksResearch
ZacksResearch Feb. 6 at 3:14 PM
$HAE beats estimates but shares drop — what’s going on? 📉 EPS of $1.31 topped estimates by 3.1%, while Q3 revenues surpassed consensus by 1.4%. Yet, shares fell 1.4% due to concerns over a 2.7% quarterly revenue decline. Full breakdown here 👉 https://www.zacks.com/stock/news/2836313/haemonetics-q3-earnings-revenues-beat-margins-up-stock-slips?cid=sm-stocktwits-2-2836313-body-32307&ADID=SYND_STOCKTWITS_TWEET_2_2836313_BODY_32307
0 · Reply
ZacksResearch
ZacksResearch Feb. 6 at 2:14 PM
Earnings beat… and the stock drops? $HAE sends mixed signals. ⚠️ Q3 EPS and revenues beat estimates with sharply higher margins, but sales fell 2.7% year over year — enough to push shares lower after the report. See what the market is focusing on 👉 https://www.zacks.com/stock/news/2836313/haemonetics-q3-earnings-revenues-beat-margins-up-stock-slips?cid=sm-stocktwits-2-2836313-teaser-32306&ADID=SYND_STOCKTWITS_TWEET_2_2836313_TEASER_32306
0 · Reply
erevnon
erevnon Feb. 6 at 1:44 PM
Barrington Research maintains Haemonetics $HAE at Outperform and raises the price target from $93 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 5 at 11:13 AM
$HAE Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.96 up 28.00% YoY • Reported revenue of $338.97M down -2.75% YoY
0 · Reply
Latest News on HAE
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Feb 23, 2026, 4:15 PM EST - 2 days ago

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

Feb 20, 2026, 4:05 PM EST - 5 days ago

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

The London Company Small Cap  Q4 2025 Performance And Trades

Feb 17, 2026, 9:27 AM EST - 8 days ago

The London Company Small Cap  Q4 2025 Performance And Trades

AWI CCC CERT DV GTES NEU RVLV

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings

Feb 6, 2026, 12:28 PM EST - 19 days ago

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings

Haemonetics Corporation (HAE) Q3 2026 Earnings Call Transcript

Feb 5, 2026, 5:34 PM EST - 20 days ago

Haemonetics Corporation (HAE) Q3 2026 Earnings Call Transcript

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Feb 5, 2026, 6:00 AM EST - 20 days ago

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Allspring Common Stock Fund Q4 2025 Performance Review

Jan 28, 2026, 9:13 AM EST - 4 weeks ago

Allspring Common Stock Fund Q4 2025 Performance Review

AAON ALNT BRKR CHWY EYE KEX RVLV

Haemonetics Corporation (HAE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 12:46 PM EST - 6 weeks ago

Haemonetics Corporation (HAE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

Jan 12, 2026, 9:00 AM EST - 6 weeks ago

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

OBIO

Vivasure Medical Announces Acquisition by Haemonetics Corporation

Jan 9, 2026, 8:00 AM EST - 6 weeks ago

Vivasure Medical Announces Acquisition by Haemonetics Corporation

Haemonetics Acquires Vivasure Medical Limited

Jan 9, 2026, 6:15 AM EST - 6 weeks ago

Haemonetics Acquires Vivasure Medical Limited

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

Jan 7, 2026, 6:17 PM EST - 7 weeks ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 2, 2026, 6:00 AM EST - 7 weeks ago

Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference

Earn Twice The Yield You Get From Bank On HAE Stock

Dec 30, 2025, 12:50 PM EST - 2 months ago

Earn Twice The Yield You Get From Bank On HAE Stock

Top 2 Health Care Stocks You May Want To Dump This Month

Dec 2, 2025, 9:01 AM EST - 3 months ago

Top 2 Health Care Stocks You May Want To Dump This Month

EXAS

Touchstone Small Company Fund Q3 2025 Performance Review

Nov 27, 2025, 9:30 AM EST - 3 months ago

Touchstone Small Company Fund Q3 2025 Performance Review

APLE CERT CIEN EME GPOR KLIC MMS

Touchstone Small Cap Fund Q3 2025 Contributors And Detractors

Nov 26, 2025, 1:09 PM EST - 3 months ago

Touchstone Small Cap Fund Q3 2025 Contributors And Detractors

AWI GHC IPAR NGVT WTM

Haemonetics Is Still Undervalued, Even After The Rally

Nov 7, 2025, 10:41 AM EST - 3 months ago

Haemonetics Is Still Undervalued, Even After The Rally

The London Company Small Cap Q3 2025 Performance Update

Nov 7, 2025, 7:25 AM EST - 3 months ago

The London Company Small Cap Q3 2025 Performance Update

AWI GHC IPAR NGVT WTM

Haemonetics Corporation (HAE) Q2 2026 Earnings Call Transcript

Nov 7, 2025, 3:26 AM EST - 3 months ago

Haemonetics Corporation (HAE) Q2 2026 Earnings Call Transcript

Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Nov 6, 2025, 6:00 AM EST - 3 months ago

Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Victory Sycamore Small Company Opportunity Fund Q3 2025 Top Contributors And Detractors

Oct 30, 2025, 2:56 PM EDT - 4 months ago

Victory Sycamore Small Company Opportunity Fund Q3 2025 Top Contributors And Detractors

BOW ECG IPAR MRCY NATL SLGN SNDK

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025

Oct 9, 2025, 4:05 PM EDT - 4 months ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025

I'm Recommending Haemonetics Again, But With Caveats (Ratings Upgrade)

Aug 11, 2025, 12:44 PM EDT - 7 months ago

I'm Recommending Haemonetics Again, But With Caveats (Ratings Upgrade)

Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

Aug 9, 2025, 10:53 PM EDT - 7 months ago

Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

Aug 8, 2025, 9:14 AM EDT - 7 months ago

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

Aug 7, 2025, 6:00 AM EDT - 7 months ago

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

Jul 9, 2025, 4:05 PM EDT - 8 months ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 6:00 AM EDT - 9 months ago

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript

May 10, 2025, 1:05 PM EDT - 10 months ago

Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

May 8, 2025, 6:00 AM EDT - 10 months ago

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

Mar 31, 2025, 4:00 PM EDT - 11 months ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

Haemonetics Announces Executive Leadership Updates

Mar 3, 2025, 4:10 PM EST - 1 year ago

Haemonetics Announces Executive Leadership Updates

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

Feb 24, 2025, 6:00 AM EST - 1 year ago

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 12:19 PM EST - 1 year ago

Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Feb 6, 2025, 6:00 AM EST - 1 year ago

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Jan 14, 2025, 6:13 AM EST - 1 year ago

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Jan 8, 2025, 5:03 PM EST - 1 year ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 6:00 AM EST - 1 year ago

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Dec 3, 2024, 1:16 AM EST - 1 year ago

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript

Nov 9, 2024, 1:34 AM EST - 1 year ago

Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Nov 7, 2024, 6:00 AM EST - 1 year ago

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Oct 3, 2024, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Top 3 Health Care Stocks That Are Set To Fly This Quarter

Aug 16, 2024, 7:57 AM EDT - 1 year ago

Top 3 Health Care Stocks That Are Set To Fly This Quarter

IBRX PGNY

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Aug 15, 2024, 6:30 AM EDT - 1 year ago

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics Corporation (HAE) Q1 2025 Earnings Call Transcript

Aug 8, 2024, 1:13 PM EDT - 1 year ago

Haemonetics Corporation (HAE) Q1 2025 Earnings Call Transcript

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Aug 8, 2024, 6:00 AM EDT - 1 year ago

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

Jul 30, 2024, 6:00 AM EDT - 1 year ago

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Jul 8, 2024, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth

Jun 21, 2024, 3:50 PM EDT - 1 year ago

Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth

OpenOutcrier
OpenOutcrier Feb. 24 at 2:05 PM
$HAE (+2.0% pre) New Haemonetics tech helps plasma centers collect more per donor https://ooc.bz/l/94447
0 · Reply
ClassiTrader
ClassiTrader Feb. 23 at 9:42 PM
$HAE $HAEMONETICS Corp Mass Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
0 · Reply
alshamiak
alshamiak Feb. 22 at 3:22 PM
$HAE #SWING
0 · Reply
dred48
dred48 Feb. 18 at 3:20 PM
$HAE switch turned on again
0 · Reply
Renecurtis
Renecurtis Feb. 9 at 4:27 PM
$HAE waiting for that 51$ to enter here
0 · Reply
Cutlass
Cutlass Feb. 6 at 3:44 PM
$HAE Load Zone 44 - 52 ✍️ Gap Nov 5 at 51.72 👀
0 · Reply
ZacksResearch
ZacksResearch Feb. 6 at 3:14 PM
$HAE beats estimates but shares drop — what’s going on? 📉 EPS of $1.31 topped estimates by 3.1%, while Q3 revenues surpassed consensus by 1.4%. Yet, shares fell 1.4% due to concerns over a 2.7% quarterly revenue decline. Full breakdown here 👉 https://www.zacks.com/stock/news/2836313/haemonetics-q3-earnings-revenues-beat-margins-up-stock-slips?cid=sm-stocktwits-2-2836313-body-32307&ADID=SYND_STOCKTWITS_TWEET_2_2836313_BODY_32307
0 · Reply
ZacksResearch
ZacksResearch Feb. 6 at 2:14 PM
Earnings beat… and the stock drops? $HAE sends mixed signals. ⚠️ Q3 EPS and revenues beat estimates with sharply higher margins, but sales fell 2.7% year over year — enough to push shares lower after the report. See what the market is focusing on 👉 https://www.zacks.com/stock/news/2836313/haemonetics-q3-earnings-revenues-beat-margins-up-stock-slips?cid=sm-stocktwits-2-2836313-teaser-32306&ADID=SYND_STOCKTWITS_TWEET_2_2836313_TEASER_32306
0 · Reply
erevnon
erevnon Feb. 6 at 1:44 PM
Barrington Research maintains Haemonetics $HAE at Outperform and raises the price target from $93 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 5 at 11:13 AM
$HAE Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.96 up 28.00% YoY • Reported revenue of $338.97M down -2.75% YoY
0 · Reply
OracleObelisk
OracleObelisk Feb. 4 at 9:31 AM
$HAE medical devices, plasma and blood management
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 4 at 2:01 AM
$HAE RSI: 4.62, MACD: -3.6222 Vol: 6.83, MA20: 73.00, MA50: 77.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
kb60521
kb60521 Feb. 2 at 7:13 PM
$HAE Post earnings 70 is reasonable???
1 · Reply
Cutlass
Cutlass Jan. 22 at 7:57 PM
$HAE Will reload at the gap around 50.00 ✍️⏰
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 4:21 PM
Is $HAE primed for growth or facing headwinds? 🤔 📈 Plasma & Hemostasis Management franchises show strong potential 📉 Dull macroeconomic scenario and fierce competition pose risks See what makes the investment case strong for $HAE 👉 https://www.zacks.com/stock/news/2818094/is-it-apt-to-retain-hae-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2818094-body-29092&ADID=SYND_STOCKTWITS_TWEET_2_2818094_BODY_29092
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 3:21 PM
Is $HAE a hold… or a trap right now? ⚠️ Haemonetics’ plasma and hemostasis franchises are showing solid growth potential, but macro headwinds and rising competition are clouding the near-term outlook. See whether HAE still earns a spot in your portfolio 👉 https://www.zacks.com/stock/news/2818094/is-it-apt-to-retain-hae-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2818094-teaser-29090&ADID=SYND_STOCKTWITS_TWEET_2_2818094_TEASER_29090
0 · Reply
Pcocc
Pcocc Jan. 13 at 5:07 PM
$HAE why is this down today?
0 · Reply
smartkarma
smartkarma Jan. 12 at 6:03 PM
$HAE | Haemonetics Acquires Vivasure—Could This Be Its Next Growth Engine? "Haemonetics Corporation is making headlines with its recent strategic move to acquire Galway, Ireland-based Vivasure Medical—a developer of..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/haemonetics-acquires-vivasure-could-this-be-its-next-growth-engine
0 · Reply
TechridyStocks
TechridyStocks Jan. 7 at 5:08 PM
$HAE is now bullish over $83.18 I added.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:05 PM
Mizuho has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Outperform with a target price of 75 → 90.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:10 PM
Baird updates rating for Haemonetics ( $HAE ) to Outperform, target set at 87 → 99.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 11:37 AM
Needham updates rating for Haemonetics ( $HAE ) to Hold.
0 · Reply